[Federal Register Volume 61, Number 170 (Friday, August 30, 1996)]
[Notices]
[Page 45975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22192]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Commission on Dietary Supplement Labels; Notice of Meeting #5

AGENCY: Office of Disease Prevention and Health Promotion.

ACTION: Commission on Dietary Supplement Labels: Notice of Meeting #5.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) is providing 
notice of the fifth meeting of the Commission on Dietary Supplement 
Labels. The Commission intends to hold its meeting on September 19, 
1996 from 8:30 a.m. to approximately 4:30 p.m. E.D.T., and September 
20, 1996 from 8:30 a.m. to 3:00 p.m. E.D.T. in Room G at the Sheraton 
Reston Hotel, 11810 Sunrise Valley Drive, Reston, Virginia 22091. The 
meeting is open to the public; seating is limited.

FOR FURTHER INFORMATION CONTACT:
Kenneth D. Fisher, Ph.D., Executive Director, Commission on Dietary 
Supplement Labels, Office of Disease Prevention and Health Promotion, 
Room 738G, Hubert H. Humphrey Building, 200 Independence Ave. SW., 
Washington, DC 20201, (202) 690-7102.

SUPPLEMENTARY INFORMATION: Public Law 103-417, Section 12, authorized 
the establishment of a Commission on Dietary Supplement Labels whose 
seven members have been appointed by the President. The appointments to 
the Commission by the President and the establishment of the Commission 
by the Secretary of Health and Human Services reflect the commitment of 
the President and the Secretary to the development of a sound and 
consistent regulatory policy on labeling of dietary supplements.
    The Commission is charged with conducting a study and providing 
recommendations for regulation of label claims and statements for 
dietary supplements, including the use of supplemental literature in 
connection with their sale and, in addition, procedures for evaluation 
of label claims. The Commission is expected to evaluate how best to 
provide truthful, scientifically valid, and non-misleading information 
to consumers in order that they may make informed health care choices 
for themselves and their families. The Commission's study report may 
include recommendations on legislation, if appropriate and necessary.
    The Commission meeting agenda will include receipt and discussion 
of ad hoc Subcommittee reports, continuation of discussion of key 
issues related to labeling of dietary supplements, and identification 
of materials to be included in the Commission's forthcoming report.
    The meeting is open to the public. If you will require a sign 
language interpreter, please call Sandra Saunders (202) 690-7102 by 
4:30 p.m. E.D.T. on September 13, 1996.

    Dated: August 26, 1996.
Linda D. Meyers,
Acting Deputy Director, Office of Disease Prevention and Health 
Promotion, U.S. Department of Health and Human Services.
[FR Doc. 96-22192 Filed 8-29-96; 8:45 am]
BILLING CODE 4160-17-M